Circadian rhythm? [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2024-01-20 13:50 (528 d 12:19 ago) – Posting: # 23834
Views: 3,714

Hi NK,

❝ We are planning a steady state bioequivalence study on healthy subject with tid dosing (every 8 hours) on day 1 to day 4. Serial PK blood sample collections are planned on Day 5 after morning dosing(expected to reach steady state concentration on day 5).

❝ Kindly clarify, whether 2nd and 3rd dose on day 5 need to be administered or not? and sampling should be continued for 24 hours?

If you have evidence from peer-reviewed literature that the PK of the drug is not subjected to a circadian rhythm, the profile after the first dose in steady state is sufficient. Otherwise, you have to dose also tid on day 5 and the primary PK metric for the extent of absorption will be AUCss,0–24h. A ‘classical’ example is theophylline.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,677 registered users;
54 visitors (0 registered, 54 guests [including 10 identified bots]).
Forum time: 03:10 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5